I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Benguerba, K.
11
results:
Search for persons
X
Format
Online (11)
Mediatypes
Articles (Online) (9)
OpenAccess-fulltext (2)
Sorted by: Relevance
Sorted by: Year
?
1
P68 Outcomes in patients with spinal muscular atrophy (SMA)..:
Finkel, R.
;
Benguerba, K.
;
Gehani, M.
...
Neuromuscular Disorders. 33 (2023) - p. S133 , 2023
Link:
https://doi.org/10.1016/..
?
2
P02 Real-world data for patients with gestational age ≤35 w..:
Finkel, R.
;
Dabbous, O.
;
Benguerba, K.
...
Neuromuscular Disorders. 33 (2023) - p. S162 , 2023
Link:
https://doi.org/10.1016/..
?
3
P.103 Onasemnogene abeparvovec (OA) treatment outcomes by p..:
Servais, L.
;
Benguerba, K.
;
De Vivo, D.
...
Neuromuscular Disorders. 32 (2022) - p. S87 , 2022
Link:
https://doi.org/10.1016/..
?
4
P.37 Outcomes in patients with spinal muscular atrophy and ..:
Finkel, R.
;
Benguerba, K.
;
Reid, A.
...
Neuromuscular Disorders. 32 (2022) - p. S58-S59 , 2022
Link:
https://doi.org/10.1016/..
?
5
P.105 Safety and effectiveness of onasemnogene abeparvovec ..:
Servais, L.
;
Benguerba, K.
;
De Vivo, D.
...
Neuromuscular Disorders. 32 (2022) - p. S87 , 2022
Link:
https://doi.org/10.1016/..
?
6
P.104 Treatments and outcomes for patients with spinal musc..:
Servais, L.
;
Benguerba, K.
;
De Vivo, D.
...
Neuromuscular Disorders. 32 (2022) - p. S87 , 2022
Link:
https://doi.org/10.1016/..
?
7
Combination disease-modifying treatment in spinal muscular ..:
Proud, CM
;
Mercuri, E
;
Finkel, RS
...
https://discovery.ucl.ac.uk/id/eprint/10177277/1/Ann%20Clin%20Transl%20Neurol%20-%202023%20-%20Proud.pdf. , 2023
Link:
https://discovery.ucl.ac..
?
8
Preparation, In Vitro Characterization, and Evaluation of P..:
Mahmood, Tahir
;
Sarfraz, Rai M.
;
Mahmood, Asif
...
ACS Omega. 9 (2024) 9 - p. 10498-10516 , 2024
Link:
https://doi.org/10.1021/..
?
9
In-silico Study of the Developed Hydroxychloroquine-based A..:
Zaher, K.
;
Masango, N. E.
;
Sobhi, W.
...
Engineering, Technology & Applied Science Research. 11 (2021) 4 - p. 7336-7342 , 2021
Link:
https://doi.org/10.48084..
?
10
Multicomponent extraction of aromatics and heteroaromatics ..:
Darwish, Ahmad S.
;
Abu Hatab, Farah
;
Lemaoui, Tarek
...
Journal of Molecular Liquids. 336 (2021) - p. 116575 , 2021
Link:
https://doi.org/10.1016/..
?
11
In-silico Study of the Developed Hydroxychloroquine-based A..:
K. Zaher
;
N. E. Masango
;
W. Sobhi
...
https://etasr.com/index.php/ETASR/article/view/4244. , 2021
Link:
https://doi.org/10.48084..
1-11
